DCAN BIOSCIENCES LLC

New York, NY · Medtech · Private

Microfluidic device for isolation and assessment of circulating tumor cells (CTCs) and CTC clusters from blood for cancer diagnosis and monitoring

Grants
$275K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I:Advanced microfluidic systems enabling development of novel circulating tumor cell diagnostics$275,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2054NEURALTHREAD INC——
2055ZEEST BIO INC——
2056CARE4QOL LLC——
2057DCAN BIOSCIENCES LLC——
2058Ropana Vascular Inc.—$100K
2059NIMBIC SYSTEMS, INC.——
2060NEUROLIGHT, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.